Technical Analysis for NOX - Noxopharm Ltd
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | 5.00% | |
| Inside Day | Range Contraction | 5.00% | |
| Wide Bands | Range Expansion | 5.00% | |
| Gapped Down | Weakness | 5.00% | |
| Oversold Stochastic | Weakness | 5.00% | |
| Hammer Candlestick | Bullish | 0.00% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 1 day ago |
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
| Up 3% | 1 day ago |
| Possible Inside Day | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Noxopharm Limited is a drug development company. The Company is engaged in the research and development of NOX66 in the field of adjuvant therapy in chemotherapy and radiotherapy. The Company focuses on developing a drug to treat cancer. The Company has a primary focus on the development of drugs to treat the problem of drug- and radio-resistance in cancer cells. The Company's drug NOX66 is a dosage formulation developed to protect idronoxil from being inactivated in the human body by Phase II metabolism. Its purpose is to ensure that idronoxil administered remains in an active form. The Company has its offices in Melbourne and Sydney.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Medicine Occupational Safety And Health Radio Cancer Drugs Clinical Medicine Resistance Therapy Drug Development Oncology Chemotherapy Radiation Therapy Cancer Treatments
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Medicine Occupational Safety And Health Radio Cancer Drugs Clinical Medicine Resistance Therapy Drug Development Oncology Chemotherapy Radiation Therapy Cancer Treatments
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.15 |
| 52 Week Low | 0.051 |
| Average Volume | 209,684 |
| 200-Day Moving Average | 0.084 |
| 50-Day Moving Average | 0.113 |
| 20-Day Moving Average | 0.116 |
| 10-Day Moving Average | 0.110 |
| Average True Range | 0.010 |
| RSI (14) | 46.24 |
| ADX | 20.13 |
| +DI | 28.442 |
| -DI | 23.783 |
| Chandelier Exit (Long, 3 ATRs) | 0.119 |
| Chandelier Exit (Short, 3 ATRs) | 0.128 |
| Upper Bollinger Bands | 0.138 |
| Lower Bollinger Band | 0.093 |
| Percent B (%b) | 0.27 |
| BandWidth | 39.134 |
| MACD Line | -0.003 |
| MACD Signal Line | -0.001 |
| MACD Histogram | -0.002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.113 | ||||
| Resistance 3 (R3) | 0.112 | 0.108 | 0.111 | ||
| Resistance 2 (R2) | 0.108 | 0.106 | 0.109 | 0.111 | |
| Resistance 1 (R1) | 0.107 | 0.105 | 0.108 | 0.108 | 0.110 |
| Pivot Point | 0.103 | 0.103 | 0.104 | 0.104 | 0.103 |
| Support 1 (S1) | 0.102 | 0.101 | 0.103 | 0.103 | 0.100 |
| Support 2 (S2) | 0.098 | 0.100 | 0.099 | 0.099 | |
| Support 3 (S3) | 0.097 | 0.098 | 0.099 | ||
| Support 4 (S4) | 0.098 |
